Scientific articles seem to suppress those easily spiraling “yes-no” debates, so here’s a fresh article on AZA for a change:
MRD-Guided Azacitidine Delays Relapse in MDS and AML
Edit: As I understand it, does it emphasize the need to develop combination therapies?